Lymphoma
📧 Sign up to get email alerts when something new happens for Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-02-06Clinical Trial Update: Study Evaluating Duvelisib in Japanese Subjects With Relapsed or Refractory Lymphoma [Phase 1]
Phase 1 study evaluating duvelisib in Japanese patients with relapsed or refractory lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2017-02-03Clinical Trial Update: Lactobacillus in Preventing Infection in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Myelodysplastic Syndrome [NA]
This clinical trial update indicates the Lactobacillus probiotic study intended to prevent infection in patients undergoing donor stem cell …
-
CLINICAL_TRIALS trial_result · 2017-01-27Clinical Trial Update: Phase I Dose Escalation Study of VS-5584 in Subjects With Advanced Non-Hematologic Malignancies or Lymphoma [Phase 1]
Clinical trial update on VS-5584 describes a Phase I dose-escalation study in patients with advanced non-hematologic malignancies or lymphom…
-
CLINICAL_TRIALS trial_result · 2017-01-23Clinical Trial Update: A Study of the HSP90 Inhibitor AUY922 [Phase 2]
The Phase 2 trial of the HSP90 inhibitor AUY922 (ganetespib) in lymphoma was terminated, with results posted in January 2017.
-
CLINICAL_TRIALS trial_result · 2017-01-19Clinical Trial Update: Bendamustine HCL in Relapsed and Primary Refractory Hodgkin Lymphoma [Phase 2]
Phase 2 clinical trial evaluating bendamustine hydrochloride for relapsed and primary refractory Hodgkin lymphoma has completed and posted r…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-01-11Clinical Trial Update: Testing a Personalize Medication Log for Patients With Lymphoma
Clinical trial update reporting completion of a study that tests a personalized medication log for patients with lymphoma.
-
CLINICAL_TRIALS trial_result · 2017-01-10Clinical Trial Update: Peripheral Blood Stem Cell (PBSC) Mobilization in Patients With Relapsed Lymphoma Treated With Bendamustine [EARLY_Phase 1]
Early-phase 1 trial update evaluating peripheral blood stem cell mobilization in relapsed lymphoma patients treated with bendamustine.
-
CLINICAL_TRIALS trial_result · 2017-01-10Clinical Trial Update: Prophylactic Use of Entecavir for HBsAg Negative/HBcAb Positive/Hepatitis B Virus DNA Negative Patients With Lymphoma [Phase 4]
Phase 4 trial investigating prophylactic Baraclude (Entecavir) to prevent hepatitis B reactivation in patients who are HBsAg negative/HBcAb …
-
CLINICAL_TRIALS trial_result · 2017-01-05Clinical Trial Update: Erythropoietin in the Treatment of Anemia After Autologous Hematopoietic Stem Cell Transplantation [Phase 4]
Phase 4 clinical trial update evaluating erythropoietin for anemia after autologous hematopoietic stem cell transplantation in lymphoma pati…
-
CLINICAL_TRIALS trial_result · 2016-12-29Clinical Trial Update: A Open Label Phase I/II Clinical Trial to Evaluate CPI-613 in Patients With Advanced Malignancies [Phase 1]
An open-label Phase 1/II clinical trial evaluating CPI-613 (devimistat) in patients with advanced malignancies has completed.
-
CLINICAL_TRIALS trial_result · 2016-12-15Clinical Trial Update: Alemtuzumab and Combination Chemotherapy Followed By Donor Lymphocytes in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer [Phase 1]
Phase 1 study evaluating alemtuzumab with combination chemotherapy followed by donor lymphocyte infusion in patients undergoing donor stem c…
-
CLINICAL_TRIALS trial_result · 2016-12-08Clinical Trial Update: Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer or Bone Marrow Failure Disorder [Phase 3]
Phase 3 trial evaluating cyclosporine eye drops to prevent eye graft-versus-host disease in patients after donor stem cell transplant for he…
-
CLINICAL_TRIALS trial_result · 2016-12-08Clinical Trial Update: Comparison of Nutritional Supplements in Preventing Weight Loss in Patients With Cancer [Phase 3]
Phase 3 trial comparing nutritional supplements to prevent weight loss in cancer patients has completed.
-
CLINICAL_TRIALS trial_result · 2016-12-01Clinical Trial Update: Phase I Study to Assess the Safety, Tolerability and Pharmacokinetics of CUDC-427 When Given to Patients With Advanced and Refractory Solid Tumors or Lymphoma [Phase 1]
A Phase I study evaluating CUDC-427 for safety, tolerability and pharmacokinetics in patients with advanced and refractory solid tumors or l…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Study Evaluating the Safety, Tolerability and Pharmacokinetics of GDC-0917 Administered to Patients With Refractory Solid Tumors or Lymphoma [Phase 1]
Phase 1 study of GDC-0917 in patients with refractory solid tumors or lymphoma has completed. The study assessed safety, tolerability, and p…
-
CLINICAL_TRIALS trial_result · 2016-10-31Clinical Trial Update: Acupuncture for Chemo-Induced Peripheral Neuropathy [Phase 2]
Phase 2 trial evaluating acupuncture to treat chemotherapy-induced peripheral neuropathy in patients with lymphoma or multiple myeloma; resu…
-
CLINICAL_TRIALS trial_result · 2016-10-28Clinical Trial Update: Pre-reinductive Decitabine and Vorinostat in Relapsed Lymphoblastic Lymphoma or Acute Lymphoblastic Leukemia [Phase 2]
A Phase 2 clinical trial investigating pre-reinductive decitabine and vorinostat in relapsed lymphoblastic lymphoma or acute lymphoblastic l…
-
CLINICAL_TRIALS trial_result · 2016-10-20Clinical Trial Update: Fungemia in Hematologic Malignancies
This clinical trial update notes the completion of a study on fungemia (fungal bloodstream infections) in patients with hematologic malignan…
-
CLINICAL_TRIALS trial_result · 2016-10-07Clinical Trial Update: Quantification of the Time and Effort Required for Peripheral Blood Stem Cell Collection -The European Perspective
This clinical trial update reports on the time and effort required to collect peripheral blood stem cells in lymphoma patients from a Europe…
-
CLINICAL_TRIALS trial_result · 2016-10-06Clinical Trial Update: Safety and Pharmacokinetic Profile of CKD-581 [Phase 1]
This Phase 1 trial evaluated the safety and pharmacokinetic profile of CKD-581 in patients with lymphoma and multiple myeloma. The study has…
-
CLINICAL_TRIALS trial_result · 2016-09-27Clinical Trial Update: A Multicenter Phase I Study of MRX34, MicroRNA miR-RX34 Liposomal Injection [Phase 1]
A multicenter Phase I study of MRX34 liposomal injection (miR-34a mimic) across several cancers has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-09-26Clinical Trial Update: Monoclonal Antibody Therapy in Treating Patients With Lymphoma or Colon Cancer That Has Not Responded to Vaccine Therapy [Phase 1]
A Phase 1 trial evaluating a monoclonal antibody therapy in patients with lymphoma or colon cancer unresponsive to vaccine therapy; the stud…
-
CLINICAL_TRIALS trial_result · 2016-09-19Clinical Trial Update: Busulfan and Fludarabine Followed by Post-transplant Cyclophosphamide [Phase 2]
Phase 2 trial evaluating a conditioning regimen of busulfan and fludarabine followed by post-transplant cyclophosphamide in patients with he…
-
CLINICAL_TRIALS trial_result · 2016-09-19Clinical Trial Update: The Efficacy and Safety of PEG-rhG-CSF in Neutropenia After Chemotherapy [Phase 4]
Phase 4 clinical trial update evaluating the efficacy and safety of PEG-rhG-CSF for neutropenia after chemotherapy in patients with breast c…
-
CLINICAL_TRIALS trial_result · 2016-09-19Clinical Trial Update: PEG-rhG-CSF in Lymphoma Patients After Autologous Hematopoietic Stem Cell Transplantation [Phase 4]
Phase 4 clinical trial update on PEG-rhG-CSF for lymphoma patients after autologous hematopoietic stem cell transplantation.